Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Merger agrmnt [a]
Quarterly results
CC transcript
Inv. presentation
Director departure
Appointed director
|
|
AMICUS THERAPEUTICS, INC. (FOLD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 4,444 shares
@ $11.079, valued at
$49.2k
Sold 1,600 shares
@ $11.7075, valued at
$18.7k
|
|
| 10/04/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,200 shares
@ $11.2027, valued at
$125.5k
Sold 500 shares
@ $12.038, valued at
$6k
Exercised 11,700 options to buy
@ $2.94, valued at
$34.4k
|
|
| 08/23/2023 |
4
| Harford Simon N.R. (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 106,973 shares
@ $0
Granted 189,043 options to buy
@ $12.62, valued at
$2.4M
|
|
| 08/21/2023 |
4
| Prout Samantha (Chief Accounting Officer) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 7,432 shares
@ $12.77, valued at
$94.9k
|
|
| 08/21/2023 |
4
| Castelli Jeff (Chief Development Officer) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 14,560 shares
@ $12.77, valued at
$185.9k
|
|
| 08/16/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $13.0268, valued at
$78.7k
|
|
| 08/11/2023 |
4
| Prout Samantha (Chief Accounting Officer) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 36,909 shares
@ $14.0056, valued at
$516.9k
Exercised 2,376 options to buy
@ $10.04, valued at
$23.9k
Exercised 5,040 options to buy
@ $9.55, valued at
$48.1k
Exercised 10,592 options to buy
@ $10.03, valued at
$106.2k
Exercised 18,901 options to buy
@ $12.11, valued at
$228.9k
|
|
| 08/03/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $13.3548, valued at
$80.7k
|
|
| 08/03/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 20,000 shares
@ $13.3937, valued at
$267.9k
Exercised 11,700 options to buy
@ $2.94, valued at
$34.4k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $12.3107, valued at
$74.4k
|
|
| 07/06/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,700 shares
@ $12.3091, valued at
$144k
Exercised 11,700 options to buy
@ $2.94, valued at
$34.4k
|
|
| 06/12/2023 |
4
| RAAB MICHAEL (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 06/12/2023 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 06/12/2023 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 06/12/2023 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 06/12/2023 |
4
| ROBERTS EIRY (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 06/12/2023 |
4
| SBLENDORIO GLENN (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 06/12/2023 |
4
| WHITMAN BURKE W (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 06/12/2023 |
4
| WHEELER CRAIG A (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 06/08/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 8,300 shares
@ $12.5032, valued at
$103.8k
|
|
| 06/05/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $11.3596, valued at
$68.7k
|
|
| 06/05/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,700 shares
@ $11.3626, valued at
$132.9k
Exercised 7,125 options to buy
@ $2.45, valued at
$17.5k
Exercised 4,575 options to buy
@ $2.94, valued at
$13.5k
|
|
| 05/19/2023 |
4
| SBLENDORIO GLENN (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Exercised 15,000 options to buy
@ $3.32, valued at
$49.8k
|
|
| 05/17/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $11.1808, valued at
$67.6k
|
|
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $11.2156, valued at
$67.8k
|
|
| 04/05/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,700 shares
@ $11.2143, valued at
$131.2k
Exercised 11,700 options to buy
@ $2.45, valued at
$28.7k
|
|
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $11.3414, valued at
$68.5k
|
|
| 03/17/2023 |
4
| Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 13,375 shares
@ $11.43, valued at
$152.9k
|
|
|
|
|